1 – 20 of 123
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Comparison of Perceptions of Skin Condition, Product Use and Allergen Reactivity Between People with Psoriasis and Controls in the European Dermato-Epidemiology Network (EDEN) Fragrance Study
(
- Contribution to journal › Article
- 2023
-
Mark
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis : Narrative Review
(
- Contribution to journal › Scientific review
-
Mark
Relationship between Eczema and Self-reported Difficulties Keeping up with School Education : A Cross-sectional Study
(
- Contribution to journal › Article
-
Mark
Establishment and Utility of SwedAD : A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy
(
- Contribution to journal › Article
-
Mark
The Hairdex quality of life instrument—A translation and psychometric validation in patients with alopecia areata
(
- Contribution to journal › Article
- 2022
-
Mark
Impact on quality of life of an intervention providing additional information to patients with allergic contact dermatitis; a randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Incidence Rate of Hand Eczema in Different Occupations : A Systematic Review and Meta-analysis
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes
(
- Contribution to journal › Article
-
Mark
Intervention study to evaluate the importance of information given to patients with contact allergy : a randomized, investigator-blinded clinical trial*
(
- Contribution to journal › Article
-
Mark
Selection process of measures for core outcome set should utilize the highest methodology level and should be maximally free of bias. Comment on ‘IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan : a group discussion study’
(
- Contribution to journal › Letter
-
Mark
European Task Force on Atopic Dermatitis : position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
(
- Contribution to journal › Letter
-
Mark
Dermatology textbooks in Scandinavia should prepare medical students for ethnic diversity
(
- Contribution to journal › Letter
-
Mark
Prevalence of contact allergies in the population compared to a tertiary referral patch test clinic in Jena/Germany
(
- Contribution to journal › Article
-
Mark
Skin exposure to scented products used in daily life and fragrance contact allergy in the European general population - The EDEN Fragrance Study
(
- Contribution to journal › Article
-
Mark
Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis : An international, cross-sectional study
(
- Contribution to journal › Article
-
Mark
Validation of questionnaire algorithm based on repeated open application testing with the constituents of fragrance mix II : the EDEN Fragrance Study
(
- Contribution to journal › Article
-
Mark
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts
(
- Contribution to journal › Letter
- 2020
-
Mark
TREatment of ATopic eczema (TREAT) Registry Taskforce : protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
(
- Contribution to journal › Article
-
Mark
Validation of a questionnaire algorithm based on repeated open application testing with the constituents of fragrance mix I
(
- Contribution to journal › Article
-
Mark
Hidradenitis Suppurativa in Sweden : A Registry-Based Cross-Sectional Study of 13,538 Patients
(
- Contribution to journal › Article